Encompass Health (EHC) EBITDA (2009 - 2026)

Encompass Health (EHC) has 18 years of EBITDA data on file, last reported at $59.7 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 69.62% year-over-year to $59.7 million; the trailing twelve-month figure through Mar 2026 stood at -$147.2 million (down 122.5% YoY), and the FY2025 full-year result was $438.3 million, down 26.53% from the prior year.
• EBITDA for Q1 2026 stood at $59.7 million, up from -$415.4 million in the prior quarter.
• Across five years, EBITDA topped out at $196.5 million in Q1 2025 and bottomed at -$415.4 million in Q4 2025.
• The 5-year median for EBITDA is $113.4 million (2023), against an average of $86.2 million.
• The widest annual swing landed in 2023, when EBITDA jumped 149.78%; it then tumbled 352.98% in 2025.
• A 5-year view of EBITDA shows it stood at $184.3 million in 2022, then sank by 52.47% to $87.6 million in 2023, then jumped by 87.44% to $164.2 million in 2024, then sank by 352.98% to -$415.4 million in 2025, then surged by 114.37% to $59.7 million in 2026.
• The last three EBITDA figures came in at $59.7 million (Q1 2026), -$415.4 million (Q4 2025), and $12.5 million (Q3 2025), per Business Quant data.

Peer Comparison